Literature DB >> 11672316

Facile Synthesis and NO-Generating Property of 4H-[1,2,5]Oxadiazolo[3,4-d]pyrimidine-5,7-dione 1-Oxides.

Magoichi Sako1, Souichi Oda, Seiji Ohara, Kosaku Hirota, Yoshifumi Maki.   

Abstract

4H-[1,2,5]Oxadiazolo[3,4-d]pyrimidine-5,7-dione 1-oxides (2) are conveniently prepared in high yields by the oxidative intramolecular cyclization of 6-amino-5-nitro-1H-pyrimidine-2,4-diones (1) employing iodosylbenzene diacetate as an oxidant in the presence of lithium hydride. The generation of nitric oxide (NO) and NO-related species from 2 occurs in the presence of thiols such as N-acetylcysteamine, cysteine, and glutathione under physiological conditions. The evidence for the NO generation derives from mechanistic interpretations for the reaction of 2 with thiols and other chemical observations.

Entities:  

Year:  1998        PMID: 11672316     DOI: 10.1021/jo980732y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats.

Authors:  Adam B Pippin; Zaira Hidayah Mohd Arshad; Ronald J Voll; Jonathon A Nye; Sussan Ghassabian; Craig M Williams; Alessandra Mancini; Dennis C Liotta; Maree T Smith; Mark M Goodman
Journal:  ACS Med Chem Lett       Date:  2016-03-30       Impact factor: 4.345

3.  Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells.

Authors:  Antonio Buzharevski; Svetlana Paskaš; Menyhárt-Botond Sárosi; Markus Laube; Peter Lönnecke; Wilma Neumann; Blagoje Murganić; Sanja Mijatović; Danijelа Maksimović-Ivanić; Jens Pietzsch; Evamarie Hey-Hawkins
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.